These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 8330302)
1. Antitumor activity and tissue distribution of bis(bilato)-1,2-cyclohexanediammineplatinum(II) complexes in BDF1 mice with murine reticulum cell sarcoma (M5076). Maeda M; Tanaka S; Ida H; Takasuka N; Uehera N; Hoshi A Cancer Lett; 1993 Jun; 70(1-2):57-64. PubMed ID: 8330302 [TBL] [Abstract][Full Text] [Related]
2. Effect of bis(bilato)-1,2-cyclohexanediammineplatinum(II) complexes on lung metastasis of B16-F10 melanoma cells in mice. Maeda M; Suga T; Takasuka N; Hoshi A; Sasaki T Cancer Lett; 1990 Dec; 55(2):143-7. PubMed ID: 2265413 [TBL] [Abstract][Full Text] [Related]
3. cis-diamineplatinum (II) complexes containing phosphono carboxylate ligands as antitumor agents. Hollis LS; Miller AV; Amundsen AR; Schurig JE; Stern EW J Med Chem; 1990 Jan; 33(1):105-11. PubMed ID: 2296007 [TBL] [Abstract][Full Text] [Related]
4. A new orally active antitumor 1R,2R-cyclohexanediamine-platinum(IV) complex: trans-(n-valerato)chloro(1R,2R-cyclohexanediamine) (oxalato)platinum(IV). Kizu R; Nakanishi T; Hayakawa K; Matsuzawa A; Eriguchi M; Takeda Y; Akiyama N; Tashiro T; Kidani Y Cancer Chemother Pharmacol; 1999; 43(2):97-105. PubMed ID: 9923814 [TBL] [Abstract][Full Text] [Related]
5. Treatment and prophylaxis of experimental liver metastases of M5076 reticulosarcoma with cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum (II) encapsulated in multilamellar vesicles. Perez-Soler R; Khokhar AR; Lopez-Berestein G Cancer Res; 1987 Dec; 47(24 Pt 1):6462-6. PubMed ID: 3315188 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and anticancer activity of [2-hydroxy-1,3-diaminopropane-kappa 2N,N'] platinum(II) complexes. Liu W; Chen X; Xie M; Lou L; Ye Q; Yu Y; Hou S J Inorg Biochem; 2008 Oct; 102(10):1942-6. PubMed ID: 18707762 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro and in vivo antitumor activity of a series of trans platinum antitumor complexes. Kelland LR; Barnard CF; Evans IG; Murrer BA; Theobald BR; Wyer SB; Goddard PM; Jones M; Valenti M; Bryant A J Med Chem; 1995 Aug; 38(16):3016-24. PubMed ID: 7636864 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, structural characterization, and antitumor properties of a novel class of large-ring platinum(II) chelate complexes incorporating the cis-1,4-diaminocyclohexane ligand in a unique locked boat conformation. Hoeschele JD; Showalter HD; Kraker AJ; Elliott WL; Roberts BJ; Kampf JW J Med Chem; 1994 Aug; 37(17):2630-6. PubMed ID: 8064793 [TBL] [Abstract][Full Text] [Related]
9. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes. Siddik ZH; al-Baker S; Thai G; Khokhar AR Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and antitumor activity of a series of [2-substituted-4,5-bis(aminomethyl)-1,3-dioxolane]platinum(II) complexes. Kim DK; Kim G; Gam J; Cho YB; Kim HT; Tai JH; Kim KH; Hong WS; Park JG J Med Chem; 1994 May; 37(10):1471-85. PubMed ID: 8182706 [TBL] [Abstract][Full Text] [Related]
11. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice. Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of platinol analogs using the M5076 murine sarcoma. Rose WC Anticancer Res; 1986; 6(4):557-62. PubMed ID: 3530116 [TBL] [Abstract][Full Text] [Related]
13. Preclinical efficacy and pharmacokinetics of AP5346, a novel diaminocyclohexane-platinum tumor-targeting drug delivery system. Rice JR; Gerberich JL; Nowotnik DP; Howell SB Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2248-54. PubMed ID: 16609041 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles. Komeda S; Takayama H; Suzuki T; Odani A; Yamori T; Chikuma M Metallomics; 2013 May; 5(5):461-8. PubMed ID: 23608770 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, physical properties, and antitumor activity of tetraplatin and related tetrachloroplatinum(IV) stereoisomers of 1,2-diaminocyclohexane. Anderson WK; Quagliato DA; Haugwitz RD; Narayanan VL; Wolpert-DeFilippes MK Cancer Treat Rep; 1986 Aug; 70(8):997-1002. PubMed ID: 3731155 [TBL] [Abstract][Full Text] [Related]
16. [Comparative studies of antitumor activities of oxalate (1R, 2R-cyclohexanediammine) platinum (II) and cis-dichlorodiammine-platinum (II) using ovarian cancer transplanted into nude mice]. Suzumori K; Yasui Y; Asai H; Yagami Y Gan To Kagaku Ryoho; 1986 Feb; 13(2):280-5. PubMed ID: 3947107 [TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of 1,2-diaminocyclohexane--platinum complexes against sarcoma-180 ascites form. Kidani Y; Inagaki K; Iigo M; Hoshi A; Kuretani K J Med Chem; 1978 Dec; 21(12):1315-8. PubMed ID: 722741 [TBL] [Abstract][Full Text] [Related]
18. Antitumor effects of three platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-platinum (II) monohydrate (DWA2114R), cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) (CBDCA) and cis-diamminedichloroplatinum(II) (CDDP), in mice. Endo K; Akamatsu K; Matsumoto T; Morikawa K; Koizumi M; Mitsui H; Koizumi K Anticancer Res; 1992; 12(1):49-58. PubMed ID: 1567181 [TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of a new platinum complex, 2-aminomethyl-pyrrolidine (1, 1-cyclobutanedicarboxylato) platinum (II). Endoh K; Akamatsu K; Matsumoto T; Morikawa K; Honda M; Mitsui H; Koizumi M; Koizumi K; Matsuno T Anticancer Res; 1989; 9(4):987-91. PubMed ID: 2817826 [TBL] [Abstract][Full Text] [Related]
20. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity. Manda T; Shimomura K; Mukumoto S; Kobayashi K; Mizota T; Hirai O; Matsumoto S; Oku T; Nishigaki F; Mori J Cancer Res; 1987 Jul; 47(14):3707-11. PubMed ID: 3594435 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]